You are here


 Leukemia cells. Image: Wikimedia commons, NIH

Research led by Weizmann Institute scientists shows why leukemia often returns

Prof. Zelig Eshhar. New approach to fighting cancer

Pools of donor immune cells could reduce the cost and expand the applications of an experimental cancer treatment.

Universal Donor Immune Cells

An approach developed at the Weizmann Institute could make a cancer therapy cheaper and more effective

Genes that delay cell division exhibit reduced levels of expression (left) after exposure to a second, delayed pulse of growth factor. Those in cells receiving a single pulse (right box) maintained high expression levels

A gene that keeps cell division in check may hold clues to chemotherapy resistance. 

(l-r) Prof. Varda Rotter, Dr. Eldad Tzahor, Dr. Ariel Rinon, Alina Molchadsky and Dr. Rachel Sarig. Migration regulation

A gene that protects us from cancer is also involved in the timing of a crucial stage of embryonic development.

Eight Hours of Resistance

Why do cancer cells easily give in to the temptation to divide?

Prof. Roy Bar-Ziv and Dr. Lior Nissim. Identifying cancer

A new genetic sensor kills only the malignant cancer cells in a test tube.

(l-r) Liat Shachnai, Natalie Yivgi-Ohana, Prof. Atan Gross, Maria Maryanovich and Dr. Yehudit Zaltsman-Amir
A newly-discovered character in the cell suicide drama may be a promising target for anti-cancer drugs
Prof. Meir Wilchek
In the late 1980s, Prof. Meir Wilchek  developed an immune cancer therapy that employs "T bodies" – white...
Prof. Emeritus Nechama Haran-Ghera
Haran-Ghera’s research provided the scientific basis for clinical trials of erythropoietin in multiple myeloma and for testing the...